BIRMINGHAM, Ala., June 19, 2013 /PRNewswire/ -- DST Health Solutions, LLC (DSTHS), a leading provider of technology solutions and services to health plans, integrated delivery systems, and health care providers, has announced that demand for its Medical Drug Management Service (MDMS) has jumped significantly.
A customizable solution used to clinically edit and automate the pricing of medical prescription drug claims, MDMS allows health plans to gain efficiencies by automating their medical drug claims processes. As specialty drug demand grows due to more individuals enrolling in Managed Medicaid and Medicare Advantage Plans, costs in the space are projected to increase by 20% annually over the next five years.
According to standard industry projections, most health plans are already overpaying between 15% and 20% on specialty and biotech medical drug claims[i].
"It's no surprise that specialty drug and biologic expenditures are becoming a major concern for health plans," says Steve Sabino, president of DST Health Solutions. "In an environment that demands new clinical competencies to avoid compliance errors, MDMS helps these plans evaluate the effectiveness of their policies and improve patient safety at the same time."
In addition, the DSTHS solution, by supporting medical policy and compliance issues, can reduce the potential sanctions and negative financial impact from increasingly frequent audits by the U.S. Department of Health and Human Services Office of Inspector General.
"In a market with few products that specifically address the potential for fraud, waste, and abuse surrounding specialty drugs and biologics, the DSTHS solution is unique in its added component of enabled clinical editing," says Tom Scully, Senior Counsel, Alston & Bird, LLP, and former CMS Administrator. "In this capacity, MDMS enables health p
|SOURCE DST Health Solutions, LLC|
Copyright©2012 PR Newswire.
All rights reserved